Forian Inc. (NASDAQ: FORA) is a data analytics company that develops information products and analytics solutions for the healthcare and financial services industries. Revenue comes from selling data-driven information products and project-based analytics services, including real-world evidence studies, longitudinal database products, and commercial analytics, primarily to healthcare stakeholders and, following the acquisition of Kyber in October 2024, to financial services clients. Forian operates a proprietary data factory that processes, integrates, de-identifies, and standardizes medical, hospital, and pharmacy claims datasets alongside point-of-sale, consumer behavior, and demographic data to produce a longitudinal database. The company redomiciled from Delaware to Maryland, effective January 9, 2026. Forian does not pay cash dividends and intends to retain earnings to fund operations and growth. As of March 27, 2026, there were approximately 252 holders of record of its common stock.

Revenue model

Forian generates revenue through sales of normalized and aggregated information products and project-based real-world evidence and data management solutions. Clients use these products for investment, clinical, and commercial decisions. The revenue mix includes recurring information product subscriptions and transactional project-based analytics engagements, though specific segment revenue percentages are not disclosed in the excerpts.

Products and services

Products include longitudinal healthcare databases, real-world evidence solutions, commercial analytics, consumer and physician marketing tools, market access analytics, healthcare economics and pharmacoeconomics services, and social determinants of health data integrations. Project-based offerings include adverse event surveillance and clinical economic outcome studies. The Kyber acquisition (October 2024) added financial services analytics capabilities.

Customers and end markets

Customers span healthcare stakeholders across the patient journey, including life sciences companies, large pharma service organizations, hospitals, and, as of October 2024, financial services firms. The company describes its pharmaceutical client penetration as early-stage as of the FY2025 10-K filing.

Value-chain role

Forian sits in the data aggregation and analytics layer, operating a data factory that ingests disparate claims and consumer datasets, applies deterministic and probabilistic matching, and delivers analytics-ready information products to end clients. It is a data intermediary and analytics provider rather than a raw data collector or end-market operator.

Geographic exposure

The filing excerpts do not specify geographic revenue mix or international operations.

Source: SEC 10-K, filed 2026-03-27

Industry: Services-Computer Processing & Data Preparation Peers: Babylon Holdings Ltd CareCloud Inc UpHealth, Inc. STREAMLINE HEALTH SOLUTIONS INC. MobileSmith, Inc. OptimizeRx Corp Pear Therapeutics, Inc. Tabula Rasa HealthCare, Inc. Akili, Inc.